Characteristics of Relapsing-Remitting Multiple Sclerosis (RRMS) Patients Switching First-Line Therapies for Different Reasons

被引：0
|
作者：
Teter, Barbara [1 ]
Agashivala, Neetu [2 ]
Hashmonay, Ron [2 ]
Weinstock-Guttman, Bianca [1 ]
机构：
[1] SUNY Buffalo, Jacobs Neurol Inst, Buffalo, NY 14260 USA
[2] Novartis Pharmaceut, E Hanover, NJ USA
来源：
NEUROLOGY | 2013年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P01212
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Impact of switching first-line diseasemodifying therapy (DIVIT) after failure in relapsing-remitting multiple sclerosis (RRMS)
    Gajofatto, A.
    Waubant, E.
    High, A.
    MULTIPLE SCLEROSIS, 2007, 13 (09): : 1224 - 1224
  • [2] Clinical and Demographic Predictors of Response to First-Line Therapies in Relapsing-Remitting Multiple Sclerosis
    Castillo-Trivino, Tamara
    Gajofatto, Alberto
    Waubant, Emmanuelle
    NEUROLOGY, 2011, 76 (09) : A72 - A72
  • [3] Reasons for switching immunomodulatory therapy in patients with relapsing-remitting multiple sclerosis
    Popiel, Malgorzata
    Bartosik-Psujek, Halina
    AKTUALNOSCI NEUROLOGICZNE, 2021, 21 (01): : 3 - 8
  • [4] Predictors of Response to First-Line Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis
    Castillo-Trivino, Tamara
    Gajofatto, Alberto
    Bacchetti, Peter
    Waubant, Emmanuelle
    NEUROLOGY, 2010, 74 (09) : A155 - A155
  • [5] Natalizumab versus fingolimod in patients with relapsing-remitting multiple sclerosis non-responding to first-line injectable therapies
    Baroncini, Damiano
    Ghezzi, Angelo
    Annovazzi, Pietro O.
    Colombo, Bruno
    Martinelli, Vittorio
    Minonzio, Giorgio
    Moiola, Lucia
    Rodegher, Mariaemma
    Zaffaroni, Mauro
    Comi, Giancarlo
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (10) : 1315 - 1326
  • [6] A retrospective chart review in patients with relapsing-remitting multiple sclerosis (RRMS)
    Cursiefen, S.
    Kanter, I.
    Niemczyk, G.
    Schicklmaier, P.
    Wernsdoerfer, C.
    Schwab, S.
    Maeurer, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 142 - 142
  • [7] Course of therapy in patients with active relapsing-remitting multiple sclerosis despite first-line treatment
    Bartosik-Psujek, Halina
    Adamczyk-Sowa, Monika
    Kulakowska, Alina
    Glazewska, Joanna
    Smaga, Anna
    Brola, Waldemar
    POSTEPY PSYCHIATRII I NEUROLOGII, 2023, 32 (02): : 59 - 67
  • [8] Reasons for switching to fingolimod in patients relapsing-remitting multiple sclerosis in France: the ESGILE study
    Tourbah, Ayman
    Papeix, Caroline
    Tourniaire, Patricia
    Rerat, Karin
    Meite, Mohamed
    Durand, Barbara
    Lamy, Fabienne
    Chouette, Isabelle
    Mekies, Claude
    Aboab, Jennyfer
    Al Khedr, Abdullatif
    Carpentier, Amer Al Najjar
    Androdias, Geraldine
    Benrabah, Rabah
    Biotti, Damien
    Bohotin, Valentin
    Bonnan, Mickael
    Bonnet, Cecilia
    Boulesteix, Jean Marc
    Brassat, David
    Busson, Philippe
    Camu, William
    Castelnovo, Giovanni
    Chapuis, Stephane
    Clavelou, Pierre
    Convers, Philippe
    Coustans, Marc
    Creange, Alain
    Delassaux, Sebastien
    Diot, Eric
    Djerdi, Madjid
    Drouet, Thomas
    Delalande, Sophie Dufour
    Pottier, Corinne Dupel
    Ferriby, Didier
    Gaida, Philippe
    Gal, Guillaume
    Giraud, Pierric
    Guilloton, Laurent
    Hascar, Tijani
    Heinzlef, Olivier
    Rouaud, Violaine Jaffrenou
    Jager, Alain
    Kubler, Christophe
    Le Coz, Patrick
    Frenay, Christine Lebrun
    Maillart, Elisabeth
    Vioud, Paris Marcel Maillet
    Malkoun, Imad
    Manchon, Eric
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 46
  • [9] Comparative effectiveness of natalizumab, fingolimod, and first-line therapies for rapidly evolving severe relapsing-remitting multiple sclerosis
    Spelman, T.
    Acosta, C.
    Hyde, R.
    Campbell, N.
    Havrdova, E.
    Horakova, D.
    Trojano, M.
    De Luca, G.
    Lugaresi, A.
    Izquierdo, G.
    Grammond, P.
    Duquette, P.
    Alroughani, R.
    Pucci, E.
    Granella, F.
    Lechner-Scott, J.
    Sola, P.
    Ferraro, D.
    Grand-Maison, F.
    Terzi, M.
    Rozsa, C.
    Boz, C.
    Hupperts, R.
    Van der Walt, A.
    Van Pesch, V.
    Oreja-Guevara, C.
    Jokubaitis, V.
    Kalincik, T.
    Butzkueven, H.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 526 - 527
  • [10] Treatment patterns in relapsing-remitting multiple sclerosis patients starting injectable versus oral first-line drug modifying therapies
    Coutinho, M.
    Faustino, P.
    Leitao, L.
    Capela, C.
    Brum, M.
    Parra, J.
    Sequeira, J.
    Barros, A.
    Araujo, C.
    Sousa, A.
    Ladeira, F.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 559 - 559
12345